Nuvation Bio Inc.
NUVB
$4.39
-$0.12-2.56%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 63.97% | 59.14% | 60.27% | -780.50% | -649.24% |
| Total Depreciation and Amortization | 154.61% | 173.41% | 154.13% | 317.41% | 207.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -90.93% | -91.32% | -92.56% | 5,535.32% | 6,281.91% |
| Change in Net Operating Assets | 4.22% | -72.87% | 111.40% | -36.31% | -2,416.11% |
| Cash from Operations | -32.98% | -91.64% | -99.73% | -144.42% | -91.79% |
| Capital Expenditure | -118.52% | -34.04% | -525.81% | -146.43% | -134.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -100.73% | -100.73% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.56% | -29.64% | 259.88% | 129.28% | 1,130.36% |
| Cash from Investing | -18.89% | -38.32% | 190.50% | 147.36% | 1,275.44% |
| Total Debt Issued | 1,566.29% | 2,806.54% | 2,806.54% | -- | -- |
| Total Debt Repaid | 27.80% | 11.85% | -82.55% | -- | -- |
| Issuance of Common Stock | 133.80% | 6.45% | 131.07% | 1,594.02% | 677.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 61,088.82% | 14,228.05% | 6,357.62% | 144.44% | -47.29% |
| Foreign Exchange rate Adjustments | -158.50% | 262.05% | 410.26% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,953.35% | 1,120.72% | 1,454.15% | 203.38% | 88.15% |